Following dichotomization of ALT responders based on a median 12.9% decrease from baseline, we found that ALT responders were younger in age and did not have severe diabetes compared with ALT non-responders
DOI: 10.2337/db08-1193 [Google Scholar] Guan G, Zhang J, Liu S, Huang W, Gong Y, Gu X
They may also have taste considerations that make daily supplementation less convenient compared to tablets or capsules
Possible Benefits: Supports cellular energy production Promotes cognitive clarity Encourages cardiovascular and metabolic health [button url= new-tab]Take the First Step Toward Healthy Aging[/button] 2
Another approved use for Trulicity is to reduce the risk of major cardiovascular disease, like heart attack or stroke, in adults with type 2 diabetes with known heart disease or multiple risk factors for heart disease
Tirzepatides dual-action mechanism targets both the GLP-1 and GIP receptors, making it a powerful tool in diabetes management